advertisement
Abstract #5924 Published in IGR 2-1
Glaucoma care updates: Financing new drug development in ophthalmology
Novack GDJournal of Glaucoma 2000; 9: 195-199
Previously, the author presented an overview of the procedural aspects of ophthalmic drug development. In that article, aspects of drug discovery and development were discussed, including application of the scientific method, compound selection, biological evaluation, pharmaceutical formulation, clinical development, and regulatory approval. An important part of drug discovery and development is funding the work. In this article, the author presents key issues involved in this funding process.
Dr. G.D. Novack, PharmaLogic Development, Inc., 17 Bridgegate Drive, San Rafael, CA 94903, USA
